Search

Individuals and families experiencing homelessness may spend a long time in an emergency shelter or transitional housing while they try to save money or arrange for a new place to live. Rapid re-housing (RRH) focuses on moving individuals and families…

Artificial intelligence (AI) is reshaping how we live, work, and interact with technology. As AI’s capabilities expand, so do its ethical and societal implications. In this master class, Dr. Nora Connor, Abt Global’s director of data science and AI, explores how AI evolved and how we can ensure its use for good.

The evaluation of the Rheumatic Fever Strategy pilot program highlights the need for integrating primordial and primary prevention approaches.

Through the Trade Adjustment Assistance Community College and Career Training (TAACCCT) program, the U.S. Department of Labor provided four rounds of grants to community colleges and other eligible institutions of higher education to expand and improve…

In this blog, Abt’s James White outlines what it might take to create resilient supply chains that can function unimpeded during crises such as COVID-19.

Approaches to link and retain vulnerable people living with HIV (PLWH) in HIV primary care are critical to ending the HIV epidemic. While evidence-informed interventions exist, they have not been broadly adopted. That’s why the Health Resources and…

Agentic AI helps federal agencies deliver faster, simpler, and more secure citizen services—driving real mission outcomes at scale.

In 2019, the Natural Resource Defense Council and other organizations filed suit against the U.S Environmental Protection Agency (EPA), alleging violations of the Clean Water Act’s (CWA) statutes regarding discharge of hazardous substances. EPA and the…

Coal mine methane (CMM) is a potent greenhouse gas (GHG) released from coal during and after coal mining that contributes to climate change if emitted within the atmosphere. In addition, CMM can be an explosive hazard inside mines, and contributes to air…

The Centers for Medicare & Medicaid Services created the Cell and Gene Therapy Access Model to be able to negotiate with manufacturers on behalf of states to make high-cost specialty drugs available to beneficiaries and affordable to State Medicaid Agencies.